Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer

Elisabeth J. M. Driessen, Maryska L. G. Janssen-Heijnen, Huub A. Maas, Anne-Marie C. Dingemans, Judith G. M. van Loon*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E849-E852
Number of pages4
JournalClinical Lung Cancer
Volume19
Issue number6
DOIs
Publication statusPublished - Nov 2018

Keywords

  • Chemoradiotherapy
  • Elderly
  • Geriatric assessment
  • Non-small cell lung cancer
  • Randomized controlled trial
  • GERIATRIC ASSESSMENT
  • SURVIVAL

Cite this